Showing results (1611-1620 of 2,482) with videos related to
Sort By:
Pageof 249
Clinical and Translational Science|May 5, 2026
Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development PerspectiveYe Yuan, Vishnu Sharma, Venkatesh Atul Bhattaram, et al.Clinical and Translational Science|May 15, 2026
Leveraging [18F]F-Piflufolastat PET for PBPK Prediction of Tissue Distribution and Therapy Optimization in Prostate CancerSuzanne van der Gaag, Mike J C Veerman, Habibe Yilmaz, et al.Clinical and Translational Science|February 26, 2026
Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK InhibitorsAnna Mandecka, Karolina Perlak, Wiktoria Bajek, et al.Clinical and Translational Science|March 4, 2026
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib and Effect on the QT/QTc Interval in Healthy ParticipantsYan Xu, Sonoko Kawakatsu, Denison Kuruvilla, et al.Clinical and Translational Science|February 27, 2026
QX008N, an Anti-TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese SubjectsZhen-Wei Shen, Qi Jiang, Kai-Qi Wu, et al.Clinical and Translational Science|March 18, 2026
Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 AllelesMatthew H Bennett, Ethan A Poweleit, Samuel E Vaughn, et al.Clinical and Translational Science|March 17, 2026
Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin-Angiotensin System Inhibitors TherapyWei-Ren Lin, Tzu-Shan Huang, Ho-Hsiang Chang, et al.Clinical and Translational Science|February 20, 2026
Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive MembranesChidtawan Hirunsomboon, Adisorn Pathumarak, Wichit Nosoongnoen, et al.Clinical and Translational Science|March 9, 2026
Is Fel d1 Based Component Resolved Diagnosis Associated With Airway Inflammation in Cat Sensitized Children?Gökhan Kaya, Hasan Yüksel, Fatma Taneli, et al.Clinical and Translational Science|March 4, 2026
Evaluation of the Effect of Food and Formulation on the Pharmacokinetics of the SHP2 Inhibitor Migoprotafib Within a Phase I Study in Cancer PatientsJulia Suchomel, Christine M Bowman, Po-Chang Chiang, et al.Pageof 249